دورية أكاديمية

Universal everolimus for malignant neuroendocrine tumours?

التفاصيل البيبلوغرافية
العنوان: Universal everolimus for malignant neuroendocrine tumours?
المؤلفون: Öberg, Kjell1 kjell.oberg@medsci.uu.se
المصدر: Lancet. 3/5/2016, Vol. 387 Issue 10022, p924-926. 3p. 1 Color Photograph.
مصطلحات موضوعية: EVEROLIMUS, NEUROENDOCRINE tumors, TREATMENT of lung tumors, GASTROINTESTINAL tumors treatment, DRUG efficacy, TUMOR treatment
مستخلص: The author comments on a study by James Yao and colleagues which examined the use of everolimus in the treatment of lung and gastrointestinal neuroendocrine tumors. Topics discussed include the anti-tumor effectiveness of everolimus by targeting the mammalian target of rapamycin (mTOR) pathway, the patients' progression-free survival, and the validity of everolimus as an alternative treatment for malignant neuroendocrine tumors.
قاعدة البيانات: Business Source Index
الوصف
تدمد:01406736
DOI:10.1016/S0140-6736(15)01234-9